🚀 ARM $31M Deep-ITM Long Call — Whale Stacks Stock-Replacement Leverage on AGI CPU + Hyperscaler Neoverse Ramp
Quick Take
At 12:40:47 ET on May 13, 2026, a single institution dropped $31 million into 5,000 contracts of the ARM August 21, 2026 $170 call — a deep in-the-money, stock-replacement structure with a delta of approximately 0.90+. This is not a speculative lottery ticket. At a spot price of $218, the $170 strike sits $48 in the money (22% ITM), meaning the call moves nearly dollar-for-dollar with the stock. The buyer is acquiring roughly 500,000 shares of economic exposure for $31M — versus the $109M+ it would cost to own the same notional in stock outright.
The timing is deliberate. FQ4 FY26 earnings (May 6, 2026) just confirmed a record quarter: $1.49B revenue (+20% YoY), data-center royalties more than doubling, and full-year FY26 revenue of $4.92B. The stock surged ≈10% post-earnings. The whale is not chasing; they are adding after confirmation of the thesis. The FQ1 FY27 earnings report — the next major catalyst — is expected in late July 2026, landing squarely inside the August 21 expiry. That print will be the first test of management's $5.7B+ FY27 guidance and the first full quarter of AGI CPU / Compute Subsystem (CSS) royalty contribution.
Three structural tailwinds underpin the position: (1) the March 24, 2026 AGI CPU launch with Meta as lead customer, representing Arm's first production silicon; (2) Microsoft Azure Cobalt 200 and NVIDIA Vera Rubin hyperscaler ramps standardizing on Neoverse V3; and (3) a royalty mix-shift toward v9 and CSS contracts commanding ≈2x the per-unit rate of legacy v8 licenses. ARM's 50% hyperscaler CPU compute share milestone in FY26 marks an inflection point that this whale clearly believes has further to run.
Company Overview
Arm Holdings plc (NASDAQ: ARM) is the dominant licensor of CPU instruction-set architecture (ISA) and processor core IP, with its designs embedded in roughly 99% of the world's smartphone application processors and a rapidly expanding footprint in cloud/data-center compute via the Neoverse product family. Headquartered in Cambridge, UK, Arm operates an asset-light, high-margin licensing + royalty model: chip designers pay an upfront license fee to access the architecture and then a per-chip royalty on every device shipped.
The company has made a strategic pivot in 2026: the March 24 AGI CPU launch (136-core Neoverse V3, TSMC 3nm, Meta as launch partner) marks Arm's first direct role in production silicon rather than pure IP licensing. This vertical move is designed to demonstrate the full potential of Neoverse CSS, accelerate hyperscaler adoption, and establish reference designs that compress customer time-to-silicon by 2–3 years.
Key figures (as of May 2026):
- Market cap: ≈$237–252B
- FY26 revenue: $4.92B (+20% YoY)
- Forward P/E: ≈110–121x (vs. ≈34x industry median)
- 52-week range: $100.02 – $239.50
- Sector: Semiconductors / Semiconductor IP, NASDAQ
The Trade
| Field | Detail |
|---|---|
| 📅 Date & Time | May 13, 2026 — 12:40:47 ET |
| 🎯 Ticker | ARM (Arm Holdings plc) |
| 📋 Order Type | BTO — Buy to Open (new long position) |
| 📊 Direction | BUY CALL |
| 💰 Strike | $170.00 |
| 📆 Expiration | August 21, 2026 (100 days to expiry) |
| 🔢 Volume | 5,000 contracts |
| 📈 Open Interest | 776 contracts (Vol/OI: 6.44x — highly unusual) |
| 💵 Premium Per Contract | $61.90 |
| 💸 Total Premium | $31,000,000 |
| 🏷️ Strategy | Long Call (Stock-Replacement / Deep ITM) |
| 📍 Spot at Trade | ≈$218 |
| 💡 Moneyness | $48 ITM — 22% in-the-money |
| ⚡ Estimated Delta | ≈0.90+ |
Vol/OI of 6.44x means this single trade printed more than 6x the entire existing open interest in this contract. That is an opening position, not a roll — confirmed by the BTO Order_Type. No prior position is being closed or managed; this is fresh, deliberate capital allocation.
Risk / Reward Profile
Breakeven Analysis
| Scenario | Price at Expiry | P&L |
|---|---|---|
| Breakeven | $231.90 | $0 (recover full $31M premium) |
| Current spot | $218.00 | -$6.95 per contract (≈-$34.75M if held to expiry flat) |
| Post-earnings re-rate (+15%) | $250.70 | +$78.10/contract = +$39.05M profit |
| 52-week high retest | $239.50 | +$67.60/contract = +$33.80M profit |
| Max loss (ARM to $170 or below) | ≤$170.00 | -$31M (100% of premium) |
Breakeven = $170 strike + $61.90 premium paid = $231.90
The stock needs to reach $231.90 by August 21, 2026 — approximately +6.4% from the $218 spot at time of trade — for the position to break even. That is a modest hurdle given: (1) the stock already moved +10% on the FQ4 print alone; and (2) the July FQ1 FY27 earnings are a second potential catalyst within the hold period.
Leverage Profile
| This Position | Equivalent Stock | |
|---|---|---|
| Capital deployed | $31M | ≈$109M |
| Shares of exposure | ≈500,000 equivalent | 500,000 |
| Upside participation | ≈$0.90 per $1 move | $1.00 per $1 move |
| Max downside | $31M (capped) | $109M (uncapped to zero) |
| Capital efficiency | 3.5x | 1x |
The deep-ITM call captures nearly all upside (delta ≈0.90+) while capping total loss at the premium paid. The capital efficiency ratio of ≈3.5x means the buyer controls $109M of stock exposure for $31M — with full upside participation and bounded downside.
Greeks Analysis
Understanding the Greeks on this deep-ITM structure is essential to appreciating why the whale chose this specific contract rather than an at-the-money or out-of-the-money call.
| Greek | Estimated Value | What It Means for This Trade |
|---|---|---|
| Delta (Δ) | ≈0.90–0.93 | For every $1 ARM rises, the position gains ≈$0.90–0.93 per contract — nearly identical to owning stock. 5,000 contracts = ≈450,000–465,000 share equivalents. |
| Gamma (Γ) | Low (≈0.005–0.008) | Gamma is minimal at this depth of ITM. Delta will not change dramatically on small moves; the position behaves like a fixed-delta stock proxy. This is intentional for a stock-replacement structure. |
| Theta (Θ) | Low-to-moderate (≈-$0.05 to -$0.10/day/contract) | Deep-ITM options have substantially lower theta drag than ATM options. With $61.90 of intrinsic value (≈$48) plus $13.90 of extrinsic, daily theta erosion is modest relative to total premium. At 100 days to expiry, the position has ample time for catalysts to materialize. |
| Vega (V) | Moderate (≈$0.25–0.35/1% IV change/contract) | Deep-ITM calls have reduced vega exposure relative to ATM calls. A 5-point IV crush (common post-earnings) would reduce the position by approximately $1.25–1.75 per contract (≈$6–9M total) — real but not catastrophic given $48 of intrinsic value underpinning the premium. |
| Rho (ρ) | Small positive | Rising interest rates modestly increase call values; a minor tailwind in a stable or rising rate environment. Not a primary driver for a 100-day position. |
Key Greek insight: The low gamma and low theta profile of a deep-ITM call makes this trade behave more like a leveraged stock position than a traditional options trade. The whale is not trying to benefit from volatility expansion (vega play) or a quick gamma squeeze — they are buying leveraged equity exposure with a defined loss floor. The $13.90 of extrinsic (time) value represents the cost of insurance against a catastrophic decline below $170.
Scenario Analysis
The following scenarios model the position's profit and loss at key price points at August 21, 2026 expiry, as well as at a mid-cycle checkpoint (July 1, 2026, approximately 50 days before expiry).
At Expiry (August 21, 2026)
| ARM Price at Expiry | Intrinsic Value | P&L Per Contract | Total P&L (5,000 contracts) | Return on Premium |
|---|---|---|---|---|
| $160 (deep bear) | $0 | -$61.90 | -$31.0M | -100% |
| $170 (max loss) | $0 | -$61.90 | -$31.0M | -100% |
| $185 | $15.00 | -$46.90 | -$23.5M | -76% |
| $200 | $30.00 | -$31.90 | -$16.0M | -52% |
| $210 | $40.00 | -$21.90 | -$11.0M | -35% |
| $218 (entry spot) | $48.00 | -$13.90 | -$7.0M | -23% |
| $231.90 (breakeven) | $61.90 | $0.00 | $0 | 0% |
| $240 (52-week high) | $70.00 | +$8.10 | +$4.1M | +13% |
| $250 | $80.00 | +$18.10 | +$9.1M | +29% |
| $260 (post-earnings re-rate) | $90.00 | +$28.10 | +$14.1M | +45% |
| $275 (full bull case) | $105.00 | +$43.10 | +$21.6M | +70% |
Mid-Cycle Mark (July 1, 2026 — Pre-Earnings, ≈50 DTE)
At 50 days to expiry with spot at various levels, the remaining extrinsic value (≈$8–10 at current IV levels) still cushions the position:
| ARM Price on July 1 | Estimated Option Value | Estimated P&L | Notes |
|---|---|---|---|
| $205 | ≈$43–45 | ≈-$17M | Pre-earnings vol support limits decay below intrinsic |
| $218 | ≈$53–56 | ≈-$6M to -$9M | Roughly breakeven on intrinsic; some extrinsic lost |
| $230 | ≈$65–68 | ≈+$3M to +$6M | Above breakeven; pre-earnings IV adds cushion |
| $245 | ≈$79–82 | ≈+$17M to +$20M | Strong mark; consider partial profit-taking ahead of earnings |
YTD Price Chart
ARM entered 2026 recovering from the January selloff that followed elevated AI capex uncertainty. The post-FQ4 gap from the high-$190s to $218+ on May 6 is visible as a step-change in the trend. The stock is now within ≈9% of its 52-week high of $239.50, with the YTD chart showing a clear pattern of higher lows since the February trough. The $218–220 range represents a key technical consolidation zone immediately ahead of the next catalyst.
Gamma Support & Resistance
Dealer gamma positioning creates mechanical price magnets and friction zones. Key levels from options market-maker hedging flows as of May 13, 2026 (spot: $219.90):
| Level | Type | Total GEX | Note |
|---|---|---|---|
| $220 | 🔴 Resistance | 3.82B | Immediate ceiling — largest single resistance node; call GEX 2.71B vs. put GEX 1.11B |
| $230 | 🔴 Resistance | 3.90B | Strongest resistance above $220; heavy call concentration |
| $240 | 🔴 Resistance | 2.17B | Secondary target zone; near 52-week high |
| $215 | 🟢 Support | 2.09B | First line of defense below spot |
| $210 | 🟢 Support | 3.12B | Strongest support; high total GEX concentration |
| $200 | 🟢 Support | 4.22B | Deep support — high combined call/put GEX |
Net GEX Bias: Bullish (total call GEX 33.5B vs. put GEX 17.5B). This means market makers are net long gamma on balance — in a rising market, their delta-hedging activity (buying stock on dips, selling on rips) creates a dampening, range-tightening effect near gamma-dense strikes. The $220 strike is the immediate friction point; a sustained break above it, supported by positive news flow, would see dealer hedging accelerate the move higher rather than resist it.
The whale's breakeven of $231.90 sits in the zone between the $230 and $240 resistance clusters — achievable but requiring a catalyst to push through sequential dealer resistance.
Implied Move
The implied move chart captures options market consensus on expected price magnitude across upcoming expirations and into the August 21 expiry. Key observations from the ARM implied move data (spot $221.49 as of May 13):
- The options market is pricing meaningful uncertainty into the late-July FQ1 FY27 earnings window, with the implied move for that event likely driving the widest single-event range in the term structure.
- The August 21 expiry encompasses both any residual post-FQ4 drift and the full FQ1 FY27 earnings event — giving this position two separate catalyst windows within a single contract.
- Deep-ITM calls with delta ≈0.90+ have minimal vega drag relative to at-the-money structures; the primary P&L driver is directional price movement (delta), not volatility expansion. This makes the position relatively robust to IV crush scenarios.
Catalyst Deep-Dive
1. FQ4 FY26 Earnings — Record Quarter Confirmed (May 6, 2026)
Arm delivered its strongest-ever quarterly result on May 6, 2026, just one week before this trade. Revenue of $1.49B (+20% YoY) beat the $1.47B consensus. Licensing revenue surged to $819M (+29% YoY) as hyperscalers committed to multi-year CSS deployments. Royalty revenue of $671M (+11% YoY) included data-center royalties that more than doubled year-over-year — the clearest evidence yet that Neoverse is taking structural compute share from x86. Full-year FY26 revenue of $4.92B marks three consecutive 20%+ growth years since IPO. Management outlined a long-term roadmap to $25B FY31 revenue and $9 EPS — a target that would justify significantly higher multiples if achieved.
2. AGI CPU + Meta Partnership — Arm Enters Production Silicon (March 24, 2026)
The most structurally significant Arm announcement in years: the March 24 AGI CPU launch revealed a 136-core Neoverse V3 data-center CPU on TSMC 3nm, designed in-house and sold to hyperscalers as a complete compute platform. Meta is the launch partner, with systems already shipping through ASRockRack, Lenovo, and Supermicro. Tom's Hardware benchmarks show >2x performance-per-rack vs. comparable x86, with Arm claiming $10B CAPEX savings per GW of AI data center capacity. This is not an incremental product announcement — it is a pivot from IP licensor to full-stack compute provider, opening a materially higher ASP and royalty tier.
3. Microsoft Azure Cobalt 200 — CSS V3 in Production
Microsoft's Azure Cobalt 200 launched with 132 Neoverse V3 cores on TSMC 3nm, built on Arm Compute Subsystem (CSS) V3. This is a $100B+ CAPEX hyperscaler standardizing its next-generation cloud CPU on Arm architecture. CSS royalties reportedly run at ≈2x the rate of traditional core licenses, meaning each Cobalt 200 shipment generates significantly higher royalty revenue per chip than prior-generation Arm data-center products.
4. NVIDIA Vera Rubin on Neoverse
NVIDIA's Vera Rubin platform continues to integrate Arm Neoverse V2/V3 for the CPU component of its AI compute nodes. As NVIDIA ramps its next-generation AI server generation in H2 2026 and into 2027, Arm collects a royalty on every Grace/Vera CPU shipped. With AI infrastructure capital spending from the top 5 hyperscalers running in the $200B+ annual range, even a modest per-unit royalty on Arm-based AI servers compounding over multiple design-win cycles is a multi-billion-dollar royalty expansion story.
5. Hyperscaler Arm Compute Share at 50% — FY26 Milestone
According to Data Center Dynamics, Arm's share of hyperscaler CPU compute hit 50% in FY26 — up from essentially zero five years ago. This is a structural market-share shift, not a cyclical uptick. The combination of Meta AGI CPU, Microsoft Cobalt 200, Google Axion, Amazon Graviton 4, and NVIDIA Grace means every major hyperscaler now has at least one Arm-native compute product in production. The royalty flywheel is in motion.
6. FQ1 FY27 Earnings — Primary Catalyst, INSIDE August 21 Expiry 🎯
The most important upcoming event for this trade is the FQ1 FY27 earnings report, expected late July 2026 — sitting squarely inside the August 21 expiry. This will be:
- The first print testing the newly issued $5.7B+ FY27 guidance
- The first quarter capturing a full three months of AGI CPU / CSS V3 royalty contribution
- The first read on whether data-center royalties can sustain triple-digit YoY growth beyond the Q4 base effect
- A potential second AGI CPU customer announcement or expanded Meta volume disclosure
A strong FQ1 FY27 print — consistent with the Q4 trajectory — could be the event that pushes ARM to new all-time highs above $239.50, delivering the $231.90+ breakeven easily.
7. Apple WWDC — June 9–13, 2026
Apple's Worldwide Developers Conference in June 2026 is expected to include A20/M5 silicon announcements and expanded Apple Intelligence AI features. Any disclosure of deeper on-device AI compute — running on Arm v9 architecture — reinforces the high-end royalty mix-shift thesis. Apple remains the single largest royalty contributor to Arm's revenue base, and v9 chips command approximately 2x the royalty rate of legacy v8.
8. Tesla AI5 + Automotive Pipeline
Futurum Research confirmed Tesla's AI5 chip (next-generation vehicle and robot SoC, claimed 40x AI performance) is built on Arm's compute platform. The software-defined vehicle megatrend is on track to triple Arm cores per automobile by 2030. Automotive royalties are a longer-duration, lower-volatility royalty stream that adds ballast to the high-growth data-center narrative.
Three Trading Ideas
Idea 1: Ride the Whale — Mirror the Position (Aggressive)
Strategy: BTO ARM Aug 21 $170 call (same contract as the whale) Rationale: Follow the exact structure. Deep-ITM at ≈0.90 delta means you are participating in virtually all of ARM's directional move between now and late July earnings. Capital at risk is the full premium per contract (≈$61.90). Appropriate only for traders comfortable with a defined-risk, high-notional position. Key levels to watch: $220 gamma resistance (immediate), $231.90 breakeven, $239.50 prior 52-week high. A close above $220 on volume would be a confirmation trigger. Risk: Full premium loss if ARM closes below $170 on August 21. More realistically, if ARM pulls back to $195–200 on RISC-V headlines or macro risk-off before earnings, the position suffers mark-to-market losses even with delta hedging the decline.
Idea 2: Defined-Risk Bull Call Spread (Moderate)
Strategy: BTO ARM Aug 21 $220 / $240 bull call spread Rationale: If you believe ARM clears the immediate $220 gamma resistance and grinds toward its 52-week high by earnings, a $220/$240 vertical captures most of the likely price range at a fraction of the cost of the ITM call. The spread is near-the-money, has a higher delta per dollar of premium, and benefits more from IV expansion than the deep-ITM call. Max profit: $20 spread width minus net debit (estimate $6–8 debit, implying ≈$12–14 max profit per spread) Breakeven: ≈$226–228 (spot + debit) Risk: Full debit loss if ARM closes at or below $220 at expiry. No intrinsic value cushion like the whale's ITM call.
Idea 3: Pre-Earnings Long Straddle (Volatility Play)
Strategy: BTO ARM July (or Aug) ATM straddle — buy both the $220 call and $220 put for the July earnings event Rationale: If you want earnings exposure without taking a directional bet, the straddle profits from any large move in either direction. ARM has delivered 10%+ post-earnings moves in recent quarters. A straddle positioned ahead of the late-July FQ1 FY27 print captures the IV expansion into the event and the realized move on the announcement. Risk: Time decay (theta) is the enemy of a straddle. If ARM stays flat into earnings and the print is in-line, IV crush after the event compresses both legs simultaneously. Best held no more than 2–3 weeks before the earnings date to minimize pre-event theta bleed. Entry timing: Watch for the FQ1 FY27 earnings date confirmation; enter 2–3 weeks prior.
Risk Factors
1. Valuation — 110–121x Forward P/E Is the Elephant in the Room
GuruFocus puts ARM's forward P/E at 110–121x versus a semiconductor industry median of ≈34x. This is not a cheap stock by any fundamental measure. The bull case requires sustained 20%+ revenue growth, continued royalty rate expansion, and no meaningful macro or competitive disruption. Any earnings miss, forward guidance cut, or macro derating of growth multiples could trigger rapid multiple compression and a 20–40% stock decline — which would still leave the whale's $170 call in the money but would generate significant mark-to-market pain.
2. China RISC-V Threat — Structural Long-Term Risk
China represents approximately 19% of ARM's total revenue. Yahoo Finance / Zacks analysis and Seeking Alpha research highlight Beijing's active state-sponsored push toward RISC-V as a means to bypass Western IP licensing entirely. China is forecast to represent ≈25% of global RISC-V revenue by 2030. Near-term, the royalty stream is intact; longer-term, a Chinese technology decoupling would remove a meaningful revenue pillar at the worst possible time for a stock priced at 110x+ earnings.
3. AGI CPU Hardware Pivot — Margin Compression Risk
The move from pure-IP licensing into first-party production silicon changes ARM's cost structure. FY25 gross margins were approximately 97% — the hallmark of an IP licensing business. Building physical chips (even via TSMC fabless model) introduces supply chain exposure, inventory risk, customer concentration in the hardware business, and potential gross margin dilution over time. If the AGI CPU cannibilizes higher-margin licensing relationships with existing customers who no longer need to license the IP themselves, the revenue transition could be dilutive to margins before it becomes accretive.
4. Royalty-Rate Ceiling and Licensee Pushback
Arm's royalty expansion story depends on continuing to charge premium rates for v9 architecture and CSS deployments at roughly 2x the v8 rate. Major licensees — Apple, Qualcomm, MediaTek, Samsung — have significant negotiating leverage and have historically pushed back on Arm royalty increases. Any public dispute, litigation, or licensing restructuring with a top-5 licensee could cap the royalty expansion thesis and trigger a multiple de-rating.
5. Position-Specific Risk — $31M in Premium at Risk
This is a defined-risk position: maximum loss is the $31M premium paid, no more. However, $31M is the entire downside — there is no partial recovery of premium if ARM closes below $170 at expiry. More practically, the risk of an interim drawdown to $190–200 (still well in-the-money but reduced intrinsic value) could cause mark-to-market losses of $10–15M before expiry, testing position conviction.
6. Macro and Semiconductor Cycle Risk
Semiconductor stocks are sensitive to macro risk-off events, Fed policy shifts, and broader AI capex narrative shifts. A surprise slowdown in hyperscaler data-center spending, triggered by a macro recession or AI ROI skepticism, could compress the entire sector regardless of ARM's company-specific fundamentals.
Bottom Line
This $31M BTO deep-ITM long call is a high-conviction, stock-replacement bet on ARM's structural re-rating as a data-center and AI infrastructure company rather than a mobile semiconductor IP licensor. The whale is using the deep-ITM structure to capture near-1:1 stock exposure with $31M versus the $109M+ required in stock, while capping maximum downside to the premium paid.
The setup has three things going for it: a confirmed record FQ4 FY26 print as the launchpad, a confirmed AGI CPU launch with the world's most advanced AI lab (Meta) as the anchor customer, and a FQ1 FY27 earnings event in late July that lands directly inside this August 21 expiry. The $231.90 breakeven — just +6.4% above the trade entry spot — is an achievable target that does not require heroic assumptions.
The primary risk is not that ARM goes to zero; it is that the stock stalls in the $210–220 range through an inconclusive FQ1 FY27 print, while the 110–121x forward P/E becomes increasingly uncomfortable in a rising-rate or growth-skeptic macro environment. That scenario does not wipe the position — it simply leaves the whale with a mark-to-market loss heading into expiry.
Catalyst Score: 8/10. The earnings-inside-expiry setup, confirmed hyperscaler adoption, and AGI CPU narrative tailwind are compelling. Valuation and RISC-V remain the key overhangs. The whale's bet is that the next leg of the data-center royalty ramp — visible in the FQ1 FY27 numbers — re-rates the stock toward $240+, at which point this position generates $40M+ in profit on $31M deployed.
Options trading involves substantial risk and is not suitable for all investors. This analysis is for informational purposes only and does not constitute investment advice. Past performance of options strategies is not indicative of future results. Always consult a qualified financial advisor before trading derivatives.